Published May 3, 2023 | Version 1.0

Protocol for a systematic review: association between airborne pollen, intermittent allergic rhinitis and blood pressure

  • 1. Swiss Tropical and Public Health Institute
  • 2. Hospital of Chengdu University of TCM

Description

Previous epidemiological studies have found an increased risk of cardiovascular morbidity and mortality following days with heightened pollen exposure and suggested that intermittent allergic rhinitis might be associated with blood pressure. Pollen sensitization and subsequent pollen exposure cause local inflammation and cytokine release in individuals with intermittent allergic rhinitis (pollen allergy). Inflammatory mediators can travel throughout the body, hence providing the physiologic basis by which pollen allergy may lead to systemic inflammation, which is known to be a risk factor for cardiovascular events. However, the findings regarding the potential association between intermittent allergic rhinitis, pollen exposure, and cardiovascular health are not fully conclusive. To date, no systematic review has been published on this topic.

This systematic review seeks to answer: Are exposure to airborne pollen and intermittent allergic rhinitis associated with blood pressure? Secondary questions include: (1) Are there personal characteristics (sex, age) which modify a potential association between intermittent allergic rhinitis or pollen exposure with blood pressure and/or hypertension? (2) What research gaps exist in our understanding of how intermittent allergic rhinitis, pollen exposure, and cardiovascular health are interrelated?

Published herein are:

  • Protocol for the systematic review, including the search strategy
  • Supplement 1: PROSPERO registration
  • Supplement 2: Data extraction table
  • Supplement 3: Risk of bias assessment strategy
  • Supplement 4: Risk of bias assessment tool

Notes

This research was funded by the Swiss National Science Foundation (SNSF), grant No. 185864 and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 853568). The project was further supported by funding from the State Scholarship Fund (Shihua Shi), China Scholarship Council (CSC, grant No. 202108510119).

Files

Supplement 1 PROSPERO registration CRD42022381907.pdf

Files (1.1 MB)

Name Size
md5:78dfa698edaa95591c24df7e174a6675
195.1 kB Preview Download
md5:fc50a25e8f79d92af8759d8c0c3d41ca
13.7 kB Download
md5:efad0ee8f30f49b50742e2defb8a7141
588.9 kB Preview Download
md5:9c654207b0aa33b4662b624164168411
13.3 kB Download
md5:896956b50171ecf356b33c040a7f4e11
284.2 kB Preview Download

Additional details

Funding

European Commission
EPOCHAL - Beyond seasonal suffering: Effects of Pollen on Cardiorespiratory Health and Allergies 853568
Swiss National Science Foundation
Effects of airborne pollen on cardiorespiratory health and allergic symptoms PZ00P3_185864